Hormone replacement therapy: informed consent without assessment?

Area of Science:

• Medical Ethics
• Transgender Healthcare
• Psychiatry

Background:

• Florence Ashley argues against mandatory mental health assessment for gender dysphoria patients seeking hormone replacement therapy (HRT), deeming it unethical.
• Ashley suggests this requirement may reflect unconscious bias against transgender individuals.

Purpose of the Study:

• To refute Florence Ashley's claims regarding the ethics of pre-HRT mental health assessments for gender dysphoria.
• To clarify the distinction between symptom self-reporting and self-diagnosis within the informed consent model.
• To support the necessity of psychological assessment and referral for transgender patients undergoing HRT.

Main Methods:

• Critically analyzing Florence Ashley's arguments on informed consent and HRT.
• Comparing the informed consent model for HRT with that of cosmetic surgery.
• Reviewing literature on psychiatric morbidity prevalence in the transgender population.

Main Results:

• Ashley conflates symptom self-reporting with self-diagnosis, deviating from standard informed consent principles.
• The informed consent model for cosmetic surgery, which Ashley favors, also includes psychological assessment and referral.
• Elevated psychiatric morbidity rates in transgender individuals support the need for mental health evaluation before HRT.

Conclusions:

• The requirement for mental health assessment before HRT for gender dysphoria is ethically justified and aligns with established medical practices.
• This process ensures informed consent and addresses the specific health needs of transgender patients.
• The findings support the continued use of psychological evaluation as a standard of care in gender-affirming hormone therapy.